Actively Recruiting
Phase 1 Study of Intravenous 18FLY4214835 to Assess Safety and Imaging in Healthy People and Cancer Patients
Led by Eli Lilly and Company · Updated on 2026-08-06
41
Participants Needed
6
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the safety and tolerance of the drug 18FLY4214835 when given by intravenous injection to both healthy volunteers and participants with cancer. This Phase 1, open-label study focuses on evaluating how the drug distributes in the body, its imaging characteristics, and the radiation dose absorbed in various organs. The study is sponsored by Eli Lilly and Company and aims to gather basic scientific knowledge over approximately 35 days of participation. Participants will receive the study drug LY4214835 intravenously. The study includes two groups one with cancer patients who either have not yet received systemic cancer treatment or whose disease has progressed after standard treatments, and another group of healthy volunteers confirmed by medical evaluation. The drug administration and imaging assessments occur mainly within the first three days following dosing. During the study, participants will undergo medical evaluations including imaging scans such as positron emission tomography PET, laboratory tests, vital sign monitoring, physical exams, and electrocardiograms. Researchers will track adverse events and measure the radiation absorbed dose in body organs to assess safety. Uptake of the drug in tumor sites and other organs will also be measured. The total study duration for participants is about 35 days, allowing for observation and follow-up after initial dosing.
CONDITIONS
Brief Title
A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer
Research Team
T
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or
P
Physicians interested in becoming principal investigators please contact
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here